|
Volumn 42, Issue 3, 2010, Pages 127-128
|
Editorial: Access to essential medicines and standard treatment for chronic diseases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
BECLOMETASONE;
BRONCHODILATING AGENT;
CORTICOSTEROID;
METHYLXANTHINE;
SALBUTAMOL;
ASTHMA;
CHRONIC DISEASE;
DEVELOPING COUNTRY;
DIABETES MELLITUS;
DOCTOR PATIENT RELATION;
DRUG COST;
EDITORIAL;
EVIDENCE BASED MEDICINE;
FINANCIAL MANAGEMENT;
GENERAL PRACTITIONER;
GOVERNMENT;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEALTH EDUCATION;
HEART DISEASE;
HUMAN;
INDIA;
INHALER;
LONG TERM CARE;
MATERNAL CARE;
MORTALITY;
NEOPLASM;
PATIENT REFERRAL;
PHARMACY;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRODUCTIVITY;
PUBLIC HEALTH;
QUALITY ADJUSTED LIFE YEAR;
RESOURCE ALLOCATION;
RESPIRATORY TRACT DISEASE;
STROKE;
WORLD HEALTH ORGANIZATION;
|
EID: 77955452836
PISSN: 02537613
EISSN: 19983751
Source Type: Journal
DOI: 10.4103/0253-7613.66830 Document Type: Editorial |
Times cited : (10)
|
References (9)
|